Clover Health Investments, Corp.

NasdaqGS:CLOV Voorraadrapport

Marktkapitalisatie: US$1.7b

Clover Health Investments Beheer

Beheer criteriumcontroles 3/4

De CEO Clover Health Investments is Andrew Toy, benoemd in Jan2023, heeft een ambtstermijn van 1.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 10.15M, bestaande uit 6.9% salaris en 93.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.61% van de aandelen van het bedrijf, ter waarde $ 10.69M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 3.7 jaar.

Belangrijke informatie

Andrew Toy

Algemeen directeur

US$10.2m

Totale compensatie

Percentage CEO-salaris6.9%
Dienstverband CEO1.8yrs
Eigendom CEO0.6%
Management gemiddelde ambtstermijn2.3yrs
Gemiddelde ambtstermijn bestuur3.7yrs

Recente managementupdates

Recent updates

Clover Health: Buy The Dip, Reap The Rewards

Nov 18

Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Nov 08
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

Clover Health's Rally: The Payoff Of A Profitable Pivot

Nov 06

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Analyse CEO-vergoeding

Hoe is Andrew Toy's beloning veranderd ten opzichte van Clover Health Investments's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$96m

Jun 30 2024n/an/a

-US$121m

Mar 31 2024n/an/a

-US$157m

Dec 31 2023US$10mUS$700k

-US$213m

Sep 30 2023n/an/a

-US$226m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$344m

Dec 31 2022US$10mUS$500k

-US$340m

Sep 30 2022n/an/a

-US$443m

Jun 30 2022n/an/a

-US$402m

Mar 31 2022n/an/a

-US$615m

Dec 31 2021US$142mUS$450k

-US$588m

Sep 30 2021n/an/a

-US$527m

Jun 30 2021n/an/a

-US$487m

Mar 31 2021n/an/a

-US$160m

Dec 31 2020US$9mUS$415k

-US$136m

Sep 30 2020n/an/a

-US$89m

Jun 30 2020n/an/a

-US$145m

Mar 31 2020n/an/a

-US$272m

Dec 31 2019US$424kUS$400k

-US$364m

Compensatie versus markt: De totale vergoeding ($USD 10.15M ) Andrew } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.54M ).

Compensatie versus inkomsten: De vergoeding van Andrew is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Andrew Toy (45 yo)

1.8yrs

Tenure

US$10,154,701

Compensatie

Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Vivek Garipalli
Co-Founder & Executive Chairman10.3yrsgeen gegevens18.01%
$ 314.9m
Andrew Toy
Co-Founder1.8yrsUS$10.15m0.61%
$ 10.7m
Karen Soares
General Counsel1.1yrsUS$1.47m0.28%
$ 4.9m
Brady Priest
Chief Executive Officer of Home Care2.3yrsUS$1.35m0.16%
$ 2.8m
Jamie Reynoso
Chief Executive Officer of Medicare Advantage1.8yrsUS$2.49m0.26%
$ 4.5m
Peter Kuipers
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Conrad Wai
Chief Technology Officer2.8yrsgeen gegevens0.69%
$ 12.1m
Derrick Nueman
Head of Investor Relations & Corporate strategyno datageen gegevensgeen gegevens
Wendy Richey
Chief Compliance Officerno datageen gegevensgeen gegevens
Rachel Fish
Chief People Officerno datageen gegevensgeen gegevens
Kumar Dharmarajan
Chief Medical Officer of Clover Assistant3yrsgeen gegevensgeen gegevens
Mark Spektor
Chief Medical Officer3.8yrsgeen gegevensgeen gegevens

2.3yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CLOV wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Vivek Garipalli
Co-Founder & Executive Chairman10.3yrsgeen gegevens18.01%
$ 314.9m
Andrew Toy
Co-Founder6yrsUS$10.15m0.61%
$ 10.7m
Lee Shapiro
Independent Director3.8yrsUS$280.93k0.066%
$ 1.2m
Thomas Tran
Directorless than a yeargeen gegevensgeen gegevens
Chelsea Clinton
Independent Director7.8yrsUS$246.55k0.067%
$ 1.2m
Phineas Barnes
Board Observerno datageen gegevensgeen gegevens
William Robinson
Independent Director3.7yrsUS$268.43k0.050%
$ 877.6k
Carladenise Edwards
Independent Director2.3yrsUS$250.30k0.041%
$ 719.1k
Anna Loengard
Independent Director2yrsUS$247.80k0.077%
$ 1.3m
Demetrios Kouzoukas
Lead Independent Director3.6yrsUS$320.16k0.044%
$ 776.8k

3.7yrs

Gemiddelde duur

50.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CLOV wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).